The Stunning Golden Parachutes of Juno's $9B Celgene Deal Post author:Sam Post published:February 4, 2018 Post category:BioPharma Juno’s Hans Bishop will take home $287M after Celgene acquired his company. Source: BioSpace You Might Also Like Ovid Release: Company Names M.D., To Scientific Advisory Board January 19, 2017 Booming Jazz Pharma Inks Huge Lease in Philadelphia to Accomodate Growth July 6, 2017 <b>The Ministry Of Health And Prevention</b> Organizes Second Emirates International Conference On Combating Drug Counterfeiting April 16, 2017
<b>The Ministry Of Health And Prevention</b> Organizes Second Emirates International Conference On Combating Drug Counterfeiting April 16, 2017
